September 3rd, 2010
Podcast 99: Blacks’ higher rate of stent thrombosis apparently has a genetic basis.
Podcast: Play in new window | Download
Subscribe: RSS
It was thought that the increased risk among blacks undergoing stenting had to do with factors such as comorbid conditions and socioeconomics. But in a study in Circulation, their rate of stent thrombosis was higher than non-blacks, even after adjusting for those factors (and despite the fact that as a group, black were more adherent to their clopidogrel regimens).
We discuss things with the paper’s senior author, Dr. Ron Waksman.
Interview-related links:
News-related links:
- Sibutramine abstract in NEJM
- ASCO guidelines on genetic screening
- JAMA article on risk-reducing surgeries
- PNAS article on chronic fatigue link to virus
Categories: Audio, clopidogrel, race, stent thrombosis, Stenting, Uncategorized
Tags: antiretrovirals, BRCA, breast cancer, chronic fatigue syndrome, clopidogrel, Meridia, ovarian cancer, pharmacogenetics, retroviruses, Ron Waksman, sibutramine, stents
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
- Podcast 261: COVID-19 as a medical disaster (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin